Moreover, the dual advantage of using SF2523 is that since BRD2/BRD4 induces pro‐fibrotic genes and promotes lung tissue fibrosis, which is majorly seen in COVID‐19 patients; therefore, inhibition of BRD2/BRD4 may prevent lung fibrosis and promote fast recovery as well. This evidence concerns the gene BRD2 and pulmonary fibrosis.